Implementation And Impact

Equip yourself with trusted, actionable knowledge designed to enhance your clinical practice.

Want to keep up with the latest news and information?

IMPLEMENTATION AND IMPACT | OCT 21 2025

Improve Star Ratings And HCC Risk Factors

Discover how the RetinaVue care delivery model empowers payors to help meet compliance goals—while increasing access to diabetic retinal exams. Learn how closing care gaps with a scalable teleretinal solution can help achieve up to 90% exam compliance in just 12 months.

View PDF

RETURN TO
IMPLEMENTATION AND IMPACT >

Read All Articles

Learn More About RetinaVue

Complete the form to learn more about the RetinaVue care delivery model.

Rx Only: For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.

Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
Any other trademarks, product names or brand images are the property of their respective owners.

US-FLC147-250025 (v3.0) 11/2025